A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508469-34-00

Acronym

C5751001 /SGNB6A-001

Enrollment

238

Registered

2024-05-20

Start date

2020-10-14

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer, Breast cancer, Cervical cancer, Esophageal cancer, Gastric cancer, Head and neck cancer, Non-small cell lung cancer, Ovarian cancer, Pancreatic cancer, Skin cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Spain

Outcome results